COVID-19 in 2022: A Year-End Wrap-Up
As year three of the COVID-19 era draws to a close, pandemic experts weigh in on the good, the bad, and the unknown of COVID-19 in 2022—and look ahead to 2023.
Addressing the global pandemic resulting from the novel coronavirus, SARS-CoV-2, the resulting illness, COVID-19.
Explore the latest public health research and insights about COVID-19.
As year three of the COVID-19 era draws to a close, pandemic experts weigh in on the good, the bad, and the unknown of COVID-19 in 2022—and look ahead to 2023.
Looking for prominent public health experts in the field of COVID-19? They’re here at the Bloomberg School of Public Health.
Sabra Klein, PhD '98, studies sex differences and the effects of pregnancy on immune responses to viruses, including influenza viruses and SARS-Cov-2, and vaccines.